Rigel Pharmaceuticals (RIGL) Tops Q4 EPS by 1354c

Rigel Pharmaceuticals (NASDAQ: RIGL) reported Q4 EPS of $13.54. Revenue for the quarter came in at $69.8 million.

For earnings history and earnings-related data on Rigel Pharmaceuticals (RIGL) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• ZenaTech raises Plurilock Security stake to 12% with new share purchase